Local News New Method Speeds Variant Tracking from Weeks to Hours UW Medicine | September 22, 2021 UW School of Medicine Microbiology Professor Evgeni Sokurenko is drawing a line in the efforts…dcorriganSeptember 22, 2021 Read More
Local News Seagen and Genmab Announce FDA Accelerated Approval for TIVDAK™ (tisotumab vedotin-tftv) in Previously Treated Recurrent or Metastatic Cervical Cancer Seagen | September 22, 2021 Seagen Inc. (Nasdaq: SGEN) and Genmab A/S (Nasdaq: GMAB) today announced that the U.S. Food and Drug Administration…dcorriganSeptember 22, 2021 Read More
Local News Seattle Biotech Alpine Immune Sciences Raises $91M for Drug Development Puget Sound Business Journal | September 20, 2021 Seattle-based biotech Alpine Immune Sciences announced Wednesday it is raising roughly $91 million, before expenses,…dcorriganSeptember 20, 2021 Read More
Local News Gut Bacteria Might Be an Indicator of Colon Cancer Risk UW Medicine | September 20, 2021 A study published today in the journal Cell Host & Microbe reported that the increased…dcorriganSeptember 20, 2021 Read More
Local News These Rare Human Neurons Generate Electrical Signals in Two Different Cellular Parts Allen Institute | September 17, 2021 It wasn’t an easy hunt. No fun scavenger clues on the way. This human brain…dcorriganSeptember 17, 2021 Read More
Local News Silverback Therapeutics Presents Interim Clinical Results from the Ongoing Phase I/Ib Study of SBT6050 Alone or In Combination with Pembrolizumab in Patients with Advanced or Metastatic HER2-Expressing Solid Tumors Silverback Therapeutics | September 17, 2021 Silverback Therapeutics, Inc., a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop…dcorriganSeptember 17, 2021 Read More
Local News Can You Lose Weight? Ask Your Microbiome Institute for Systems Biology | September 15, 2021 The strongest associations with weight loss success or failure – independent of BMI – are…dcorriganSeptember 15, 2021 Read More
Local News RareCyte® Secures $24M Financing to Advance the Orion™ Spatial Biology Platform and Expand Global Commercial Channels RareCyte | September 15, 2021 RareCyte, Inc., a Life Sciences company developing and manufacturing proprietary platforms enabling precision biology solutions,…dcorriganSeptember 15, 2021 Read More
Local News Seattle Startup Cyrus Inks Protein-Design Deal with Immune Biotech Selecta Worth Up to $1.5 Billion GeekWire | September 15, 2021 Seattle-based Cyrus Biotechnology is entering a protein engineering collaboration with Boston-based Selecta Biosciences that could…dcorriganSeptember 15, 2021 Read More
Local News Icosavax Initiates Phase I/Ib Trial of VLP Vaccine Candidate Against Respiratory Syncytial Virus Icosavax | September 13, 2021 Icosavax, Inc., a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop…dcorriganSeptember 13, 2021 Read More